Skip to main content

NIH Websites Are Changing
Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.

pyruvate kinase inhibitor TLN-232

A synthetic cyclic heptapeptide with potential antineoplastic activity. Pyruvate kinase (PK) inhibitor TLN-232 targets pyruvate kinase M2 (M2PK), which may disrupt tumor cell anaerobic glycolysis. M2PK is a dimeric isoform of PK and the predominant PK isoform found in tumor cells.

Check for active clinical trials using this agent View this agent in the NCI Thesaurus

Code name:	CAP-232 TLN-232

pyruvate kinase inhibitor TLN-232

Search NCI's Drug Dictionary